Dr. Aaron Pace, M.D.
Dermatology (Dermatology Physician)
1901 S Union Ave Ste B3003
Tacoma, WA 98405
Who else practices at this address →
Pierce County includes primary care (20% of residents) and dental (11% of residents) and mental health (11% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Loyola University of Chicago, Stritch School of Medicine (2007)
- Years since graduation
- 19
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 766
Licensed in Washington since 2010, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Medical school: Loyola University of Chicago, Stritch School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
WA license 60195226 (first issued 2010; active) · IL license 125052525
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Pace Dermatology Associates, PLLC (15 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 766
- Services billed
- 4,706
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 2,554 | 371 |
| Established patient office or other outpatient visit, 30-39 minutes | 674 | 499 |
| Destruction of precancer skin growth, 1 growth | 560 | 424 |
| Established patient office or other outpatient visit, 20-29 minutes | 461 | 378 |
| Destruction of skin growth, 1-14 growths | 391 | 321 |
| Biopsy of related skin growth, first growth | 280 | 242 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 126 | 111 |
| Destruction of precancer skin growth, 15 or more growths | 85 | 71 |
| Strapping, unna boot | 70 | 15 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 65 | 61 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ketoconazole Other prescribers in Tacoma, WA | 257 |
| Triamcinolone Acetonide Other prescribers in Tacoma, WA | 114 |
| Cephalexin Other prescribers in Tacoma, WA | 99 |
| Metronidazole Other prescribers in Tacoma, WA | 92 |
| Clobetasol Propionate Other prescribers in Tacoma, WA | 77 |
| Hydrocortisone Other prescribers in Tacoma, WA | 49 |
| Betamethasone Diprop Augmented (betamethasone/propylene glyc) | 39 |
| Betamethasone Dipropionate Other prescribers in Tacoma, WA | 36 |
| Fluocinonide Other prescribers in Tacoma, WA | 20 |
| Doxycycline Monohydrate Other prescribers in Tacoma, WA | 18 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 41 payments worth $998 in total to this clinician.
| Pfizer Inc. | $408 |
|---|---|
| Janssen Biotech, Inc. | $190 |
| AbbVie Inc. | $182 |
| Novartis Pharmaceuticals Corporation | $98.21 |
| Genzyme Corporation | $65.88 |
| E.r. Squibb & Sons, L.l.c. | $32.56 |
| UCB, Inc. | $21.68 |
| Food and Beverage | $808 |
|---|---|
| Education | $190 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Apr 25, 2025 | Education TREMFYA · Immunology · in-kind | $99.99 |
| Janssen Biotech, Inc. Nov 20, 2025 | Education TREMFYA · Immunology · in-kind | $89.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.